Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 173

1.

Protective actions of sex steroid hormones in Alzheimer's disease.

Pike CJ, Carroll JC, Rosario ER, Barron AM.

Front Neuroendocrinol. 2009 Jul;30(2):239-58. doi: 10.1016/j.yfrne.2009.04.015. Epub 2009 May 7. Review.

2.

The potential use of hormone-based therapeutics for the treatment of Alzheimer's disease.

Carroll JC, Rosario ER.

Curr Alzheimer Res. 2012 Jan;9(1):18-34. Review.

PMID:
22329650
3.

Sex hormones, aging, and Alzheimer's disease.

Barron AM, Pike CJ.

Front Biosci (Elite Ed). 2012 Jan 1;4:976-97. Review.

4.

Gender, sex steroid hormones, and Alzheimer's disease.

Vest RS, Pike CJ.

Horm Behav. 2013 Feb;63(2):301-7. doi: 10.1016/j.yhbeh.2012.04.006. Epub 2012 Apr 19. Review.

5.

Effects of sex hormones on Alzheimer's disease-associated β-amyloid oligomer formation in vitro.

Morinaga A, Ono K, Takasaki J, Ikeda T, Hirohata M, Yamada M.

Exp Neurol. 2011 Apr;228(2):298-302. doi: 10.1016/j.expneurol.2011.01.011. Epub 2011 Jan 31.

PMID:
21281631
6.

Testosterone regulation of Alzheimer-like neuropathology in male 3xTg-AD mice involves both estrogen and androgen pathways.

Rosario ER, Carroll J, Pike CJ.

Brain Res. 2010 Nov 4;1359:281-90. doi: 10.1016/j.brainres.2010.08.068. Epub 2010 Aug 31.

8.

Sex and the development of Alzheimer's disease.

Pike CJ.

J Neurosci Res. 2017 Jan 2;95(1-2):671-680. doi: 10.1002/jnr.23827. Review.

9.

Reproductive hormones modulate oxidative stress in Alzheimer's disease.

Barron AM, Fuller SJ, Verdile G, Martins RN.

Antioxid Redox Signal. 2006 Nov-Dec;8(11-12):2047-59. Review.

PMID:
17034349
10.

Androgen regulation of beta-amyloid protein and the risk of Alzheimer's disease.

Rosario ER, Pike CJ.

Brain Res Rev. 2008 Mar;57(2):444-53. Epub 2007 Jul 7. Review.

12.

Alzheimer's disease: review of hormone therapy trials and implications for treatment and prevention after menopause.

Henderson VW.

J Steroid Biochem Mol Biol. 2014 Jul;142:99-106. doi: 10.1016/j.jsbmb.2013.05.010. Epub 2013 May 28. Review.

13.

Androgen cell signaling pathways involved in neuroprotective actions.

Pike CJ, Nguyen TV, Ramsden M, Yao M, Murphy MP, Rosario ER.

Horm Behav. 2008 May;53(5):693-705. doi: 10.1016/j.yhbeh.2007.11.006. Epub 2007 Nov 22. Review.

14.

Update on the neuroprotective effect of estrogen receptor alpha against Alzheimer's disease.

Lan YL, Zhao J, Li S.

J Alzheimers Dis. 2015;43(4):1137-48. doi: 10.3233/JAD-141875. Review.

PMID:
25159676
15.

Alzheimer, mitochondria and gender.

Grimm A, Mensah-Nyagan AG, Eckert A.

Neurosci Biobehav Rev. 2016 Aug;67:89-101. doi: 10.1016/j.neubiorev.2016.04.012. Epub 2016 Apr 29. Review.

PMID:
27139022
16.

Estradiol and tamoxifen differentially regulate a plasmalemmal voltage-dependent anion channel involved in amyloid-beta induced neurotoxicity.

Herrera JL, Fernandez C, Diaz M, Cury D, Marin R.

Steroids. 2011 Aug;76(9):840-4. doi: 10.1016/j.steroids.2011.02.014. Epub 2011 Feb 25. Review.

PMID:
21354436
17.

Continuous and cyclic progesterone differentially interact with estradiol in the regulation of Alzheimer-like pathology in female 3xTransgenic-Alzheimer's disease mice.

Carroll JC, Rosario ER, Villamagna A, Pike CJ.

Endocrinology. 2010 Jun;151(6):2713-22. doi: 10.1210/en.2009-1487. Epub 2010 Apr 21.

18.

Brain levels of sex steroid hormones in men and women during normal aging and in Alzheimer's disease.

Rosario ER, Chang L, Head EH, Stanczyk FZ, Pike CJ.

Neurobiol Aging. 2011 Apr;32(4):604-13. doi: 10.1016/j.neurobiolaging.2009.04.008. Epub 2009 May 9.

19.

Alzheimer's disease, apolipoprotein E and hormone replacement therapy.

Depypere H, Vierin A, Weyers S, Sieben A.

Maturitas. 2016 Dec;94:98-105. doi: 10.1016/j.maturitas.2016.09.009. Epub 2016 Sep 29. Review.

PMID:
27823753
20.

The estrogen myth: potential use of gonadotropin-releasing hormone agonists for the treatment of Alzheimer's disease.

Casadesus G, Garrett MR, Webber KM, Hartzler AW, Atwood CS, Perry G, Bowen RL, Smith MA.

Drugs R D. 2006;7(3):187-93. Review.

PMID:
16752944

Supplemental Content

Support Center